Ranitidine (McKesson Packaging Services Business Unit of McKesson Corporation)
Welcome to the PulseAid listing for the Ranitidine drug offered from McKesson Packaging Services Business Unit of McKesson Corporation. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | McKesson Packaging Services Business Unit of McKesson Corporation |
NON-PROPRIETARY NAME: | Ranitidine |
SUBSTANCE NAME: | RANITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-07-01 |
END MARKETING DATE: | 0000-00-00 |
Ranitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Ranitidine from McKesson Packaging Services Business Unit of McKesson Corporation |
LABELER NAME: | McKesson Packaging Services Business Unit of McKesson Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2004-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63739-266_7b5c59ae-e4c1-4097-9db1-f6837b7c3688 |
PRODUCT NDC: | 63739-266 |
APPLICATION NUMBER: | ANDA075180 |
Other RANITIDINE Pharmaceutical Manufacturers / Labelers: